<!doctype html>
<html>
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width">
<title></title>
<link rel="stylesheet" href="css/style.css">
</head>

<body>

<header>
  <div class="l"><a href="javascript:history.back();"><span>left</span></a></div>
  <p class="title"><a href="index.html">社外秘 研修資料</a></p>
  <div class="r"><a href="203.html"><span>right</span></a></div>
</header>

<div class="wrap">
  <div class="clearfix">
  <img src="img04/multi.png" alt="マルチスタジオ非掲載" width="110" height="20" style="float: right;">
</div>
  <section>
    <h1 class="tit">TNF製剤はMTXと併用した方が効果が高い</h1>
  </section>

  <section>
    <p class="txt"><strong>JESMR 52週の関節破壊に対するETNの効果</strong></p>
    <div class="img"><img src="img/86-1.png" alt=""></div>
    <div class="img"><img src="img/86-2.png" alt=""></div>
    <div class="img"><img src="img/86-3.png" alt=""></div>
    <div class="greenbox"><p class="txt"><strong>エンブレルは、MTXとの併用で寛解率も関節破壊進展抑制効果も上がる</strong></p>
    <ul class="circle_n">
    	<li><span><strong>⇒</span>できる限りMTX併用による治療を行う必要がある（原著にもそう書かれている）</strong></li>
    </ul></div>
    <p class="txt sml right"><a href="http://maps.ty.chugai-pharm.co.jp/Search/Detail.aspx?id=D67762&skey=db4118d9-5e2d-4fb9-8245-053899e37b9d">Kameda, et. Al. The Journal of Rheumatology 2011; 38:8</a></span>


  </section>


</div>

<footer>
  <div class="l"><a href="javascript:history.back();"><span>left</span></a></div>
  <div class="home"><a href="index.html"><span>HOME</span></a></div>
  <div class="r"><a href="203.html"><span>right</span></a></div>
  <div class="pagetop"><a href="javascript:scroll(0,0);">pagetop</a></div>
</footer>

<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.2/jquery.min.js"></script>
<script src="js/common.js"></script>
</body>
</html>
